Menu Back toSession-11-Hot-Topics

Pharmacovigilance and Risk Management Strategies Conference

Session 11: Hot Topics

    Session Chair(s)
      Michael  Richardson, MD, FFPM

      Michael Richardson, MD, FFPM

      • International GPV&E and EU QPPV
      • Bristol-Myers Squibb, United Kingdom
    Session 11: Hot Topics
      Mark  Perrott, PhD

      Digital Approach to Risk Minimization

      Mark Perrott, PhD

      • Head of Development Consulting
      • Pope Woodhead & Associates Ltd, United Kingdom
      Jeremy  Jokinen, PhD, MS

      Value of Safety Information Data Sources

      Jeremy Jokinen, PhD, MS

      • Sr Director, Safety Decision Analytics
      • AbbVie, Inc., United States
      Peter  Verdru, MD


      Peter Verdru, MD

      • Vice President, Head of Patient Safety
      • UCB Biopharma S.P.R.L., Belgium
      Vicki  Edwards, RPh


      Vicki Edwards, RPh

      • Vice President, Pharmacovigilance Excellence and QPPV
      • AbbVie, Inc., United Kingdom
      Representative Invited


      Representative Invited

      • FDA CDER Office of Surveillance and Epidemiology, United States